alkermes plc (ALKS:NASDAQ GS)
Transactions by ALKERMES PLC (ALKS) in the last 6 months
Civitas Therapeutics, Inc. announced that it will receive $38,299,999 in its equity round of funding on September 3, 2013. The round will include participation from 11 investors. The company will issue securities pursuant to exemption provided under Regulation D.
On September 11, 2013, the company received $38,000,000 in its series B round of funding led by new investor, Bay City Capital LLC. The round included participation from new investor, RA Capital Management, ...
Bay City Capital LLC
Fountain Healthcare Partners
Longitude Capital Management Co., LLC
RA Capital Management, LLC
|BioMarin Pharmaceutical Inc||$69.80 USD||-0.36|
|Dendreon Corp||$2.97 USD||-0.04|
|Jazz Pharmaceuticals Plc||$117.39 USD||+0.35|
|Lupin Ltd||852.90 INR||-4.95|
|Nektar Therapeutics||$11.34 USD||-0.20|
|View Industry Companies|